JANX · Janux Therapeutics, Inc.
$17.28
-0.24 (-1.37%)
At close · Aug 20
Market Cap
$1.07B
Shares
61.14M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-06-23 | — | |
| 8-K | 2026-06-12 | 2026-06-11 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-06-11 | |
| 8-K | 2026-04-28 | — | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-22 | 2026-01-21 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-19 | 2025-09-18 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-13 | 2025-06-11 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-25 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2024-12-05 | 2024-12-04 | |
| 8-K | 2024-12-02 | — | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-07-22 | 2024-07-19 | |
| 8-K | 2024-06-28 | 2024-06-26 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | 2024-05-07 | |
| DEF 14A | 2024-04-29 | 2024-06-26 | |
| 10-K | 2024-03-08 | 2023-12-31 | |
| 8-K | 2024-03-08 | — | |
| 8-K | 2024-02-29 | 2024-02-28 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-02-26 | — | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-07-18 | 2023-07-17 | |
| 8-K | 2023-07-17 | — | |
| 8-K | 2023-06-23 | 2023-06-21 | |
| 8-K | 2023-06-20 | 2023-06-14 | |
| 8-K | 2023-05-09 | — | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — |
Showing 1–50 of 75 filings